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OBJECTIVE — Weexaminedthejointeffectsofinsomniaandobjectiveshortsleepduration,
the combination of which is associated with higher morbidity, on diabetes risk.
RESEARCH DESIGN AND METHODS — A total of 1,741 men and women randomly
selected from Central Pennsylvania were studied in the sleep laboratory. Insomnia was deﬁned
by a complaint of insomnia with duration of 1 year, whereas poor sleep was deﬁned as a
complaintofdifﬁcultyfallingasleep,stayingasleep,orearlyﬁnalawakening.Polysomnographic
sleep duration was classiﬁed into three categories: 6 h of sleep (top 50% of the sample); 5–6
h (approximately third quartile of the sample); and 5 h (approximately the bottom quartile of
the sample). Diabetes was deﬁned either based on a fasting blood glucose 126 mg/dl or use of
medication. In the logistic regression model, we simultaneously adjusted for age, race, sex, BMI,
smoking, alcohol use, depression, sleep-disordered breathing, and periodic limb movement.
RESULTS — Chronic insomnia but not poor sleep was associated with a higher risk for
diabetes.Comparedwiththenormalsleepingand6hsleepdurationgroup,thehighestriskof
diabetes was in individuals with insomnia and 5 h sleep duration group (odds ratio [95% CI]
2.95 [1.2–7.0]) and in insomniacs who slept 5–6 h (2.07 [0.68–6.4]).
CONCLUSIONS — Insomnia with short sleep duration is associated with increased odds of
diabetes. Objective sleep duration may predict cardiometabolic morbidity of chronic insomnia,
the medical impact of which has been underestimated.
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M
any studies have established that
insomnia, the most common
sleepdisorder,ishighlycomorbid
with psychiatric disorders and is a risk
factor for the development of depression,
anxiety, and suicide (1,2). In contrast
with sleep-disordered breathing (SDB),
the second most common sleep disorder,
chronic insomnia has not been associated
with signiﬁcant medical morbidity, e.g.,
cardiovascular disorders (3,4).
Recently, we demonstrated that in-
somnia with objective short sleep dura-
tion is associated with a high risk for
hypertension (5). These data suggest that
objectivesleepmeasuresininsomniapro-
vide an index of the severity of the disor-
der and that the more severe form of
insomnia is most likely associated with
morbidity and possibly mortality. This
hypothesis is further supported by phys-
iological studies, which demonstrated
that activation of the hypothalamic-
pituitary-adrenal (HPA) axis and auto-
nomic system, including increased heart
rate, 24-h metabolic rate, and impaired
heart rate variability, is present in insom-
niacs who meet both subjective and ob-
jectivepolysomnographiccriteria(6–11).
Given the association of the HPA axis and
sympathetic system activation with the
pathogenesis of metabolic disorders, in-
cluding diabetes (12), we hypothesized
that insomnia with objective short sleep
duration will be associated with type 2
diabetes.
Previous studies have shown that
sleepdisturbancesorcomplaintsareasso-
ciated with increased incidence of type 2
diabetes(13–16).However,inthesestud-
ies,thepresenceofsleepdisturbanceswas
based only on a subjective questionnaire
and did not control for obstructive sleep
apnea, a sleep disorder whose association
with diabetes and insulin resistance is
well established (12). Thus, it is not
known whether insomnia per se is asso-
ciated with an increased risk for diabetes.
To test this hypothesis, we examined
the joint effects of the complaints of
chronic insomnia and poor sleep (a
milder form of insomnia) and objective
sleepdurationontheprevalenceofdiabe-
tes in a large cross-sectional population-
based sample from Central Pennsylvania
(Penn State Cohort).
RESEARCH DESIGN AND
METHODS— Thedatawerecollected
aspartofatwo-phaseprotocolwhosepri-
marypurposewastoestablishtheagedis-
tributionofSDB(17,18).Intheﬁrstphase
of the study, a sample of adult men and
women (aged 20 years) was randomly
selected from local telephone households
in two counties of Central Pennsylvania
(Dauphin and Lebanon) using the Mitofsky-
Waksberg two-stage random digit dialing
procedure. A within-household selection
procedure described by Kish was used to
select the speciﬁc man or woman to be
interviewed. Telephone interviews were
conducted with 4,364 age-eligible men
and 12,219 age-eligible women residing
in the sample households for a total sam-
ple of 16,583 with response rates of 73.5
and 74.1%, respectively. The question-
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demographic and sleep information.
In the second phase of this study, a
subsample of 741 men and 1,000 women
selected from those subjects previously
interviewed by telephone were studied in
our sleep laboratory. The sample of men
waschosenbycountinghowmanyoffour
risk factors (snoring, daytime sleepiness,
obesity, and hypertension) each inter-
viewed subject reported. Subjects with
higher counts of risk factors were over-
sampled(3,9,32,45,and70%for0,1,2,
3, and 4 symptoms reported, respec-
tively). The sample of women was chosen
by counting how many of ﬁve risk factors
(snoring, daytime sleepiness, obesity, hy-
pertension, and menopause) were re-
ported by each interviewed subject.
Those with higher counts of risk factors
were oversampled (2, 4, 10, 27, 51, and
56% of those with 0, 1, 2, 3, 4, and 5
symptoms reported, respectively). The
response rates for this phase were 67.8
and 65.8% for men and women, respec-
tively. There were no signiﬁcant differ-
ences between those subjects who were
recorded in the laboratory and those who
were selected but were not recorded in
terms of age, BMI, reported use of medi-
cation for hypertension or diabetes, and
prevalence of sleep disorders. Each sub-
ject selected for laboratory evaluation
completed a comprehensive sleep history
and physical examination and was con-
tinuously monitored for one night for 8 h
using 16-channel polygraphs including
an electroencephalogram, electrooculo-
gram, and electromyogram. Bedtimes
were adjusted to conform to subjects’
usual bedtimes, and recordings were
done between 10:00 and 11:00 P.M. and
6:00and7:00 A.M.Thesleeprecordswere
subsequently scored independently ac-
cording to standardized criteria. Percent
sleep time is total sleep time (duration of
sleep) divided by recorded time in bed
and multiplied by 100. Respiration was
monitored throughout the night by use of
thermocouples at the nose and mouth
and thoracic strain gauges. All-night re-
cordings of hemoglobin oxygen satura-
tion (SaO2) were obtained with an
oximeter attached to the ﬁnger.
Key measurements
Diabetes was deﬁned as being medically
treated for diabetes or having fasting
blood glucose 126 mg/dl from blood
drawn the morning after the sleep labora-
tory testing. Hypertension was deﬁned as
diastolic blood pressure 90 mmHg or
systolic blood pressure 140 mmHg
at the time of the sleep laboratory evalua-
tion or the use of antihypertension
medication.
The presence of sleep disorders was
based on a standardized questionnaire
completed by the subjects on the evening
of their sleep laboratory visit. This ques-
tionnaire consists of 53 questions (7 de-
mographic, 20 sleep-related, and 26
general health questions). In addition,
women responded to eight questions re-
lated to menstrual history, menopause,
and hormone therapy (for more details,
seeref.5).Thepresenceofsleepdifﬁculty
wasestablishedonthreelevelsofseverity.
First, insomnia was deﬁned by a com-
plaint of insomnia with a duration of at
least 1 year. Second, poor sleep was de-
ﬁned as a moderate to severe complaint
(based on a mild to severe scale) of difﬁ-
culty falling asleep, difﬁculty staying
asleep, early ﬁnal awakening, or unre-
freshingsleep.Tocreatetwomutuallyex-
clusive categories, the insomnia group
could include those who reported one or
more of the four symptoms of poor sleep,
whereasnoneofthepoorsleepgrouphad
a complaint of insomnia. Third, normal
sleeping was deﬁned as the absence of ei-
ther of these two categories.
From the objectively recorded sleep
time data, we regrouped the entire study
sampleintothreeordinalgroupsbasedon
standard mathematical approaches using
as cutoff points the 50th percentile and
the 25th percentile: the top 50% of per-
sons above the median percent sleep time
(“normalsleepdurationgroup”),the25%
of persons in the third quartile (“moder-
ately short sleep duration group”), and
the bottom 25% of persons (“severely
short sleep duration group”). We then
rounded the quartile cutoff points to
practically meaningful numbers. Thus,
we created the following three relative
sleep duration groups: the normal sleep
duration group consisted of those who
slept 6 h, the moderately short sleep
duration group consisted of those who
slept 5–6 h, and the severely short sleep
duration group consisted of those who
slept 5h .
To control for possible confounding
variablesinﬂuencingtherelationbetween
insomnia and diabetes in the subsample
of 1,741, we ascertained whether the re-
spondent was currently treated for de-
pression (including a history of suicidal
thoughts or attempts), had a history of
smoking (current use of any type of to-
bacco product), had a history of alcohol
use (more than two alcohol drinks per
day), and had sleep apnea or periodic
limb movements. For the purpose of this
study, sleep apnea was deﬁned as an ob-
structive apnea or hypopnea index of 5
(5,17,18). The condition of periodic limb
movement was considered present when
there were ﬁve or more movements per
hour of sleep, and leg movements were
scored according to standardized criteria
(5). BMI was based on measured height
(centimeters) and weight (kilograms)
during the subjects’ sleep laboratory visit,
and data are presented in terms of mean,
percentile distribution, and prevalence
within each category.
Statistical analyses
The design of this study included over-
sampling of those at higher risk for SDB
and women with markedly higher levels
ofBMItoincreasetheprecisionoftherisk
estimates. Because of this sampling strat-
egy, numeric sampling weights were de-
veloped for the analysis so that the
estimates could be inferred to the original
target population (5,17,18). Speciﬁcally,
three weights were created for the men.
First, in the telephone sample, 32 of the
963clustersofphonenumbersintheﬁrst
stage were “exhausted” before the target
sample size was obtained. A compensa-
tory weight was computed that corrected
for this problem. A second weight was
computed because the within-household
screening deliberately introduced un-
equal probabilities of selection across the
three age-groups to oversample the mid-
dle age-group. The ﬁnal weight for the
men was computed to account for the
oversamplingofsubjectsforthesleeplab-
oratory study (phase II); those with larger
counts of the four possible risk factors,
i.e., snoring, daytime sleepiness, obesity,
and hypertension, had substantially
higher probability of being selected. For
the women, the only weight required was
to account for the oversampling of sub-
jects for the sleep laboratory study. To
eliminate any suggestion of possible sam-
ple bias, we calculated 32 unique weights
for the women and 16 unique weights for
the men corresponding to all possible
combinations of the ﬁve risk factors for
the women and four for the men. Any
individual weight that had too small of a
cellsizewascombinedwithadjacentcells
so that 10% of the cells had a sample
25, and no cell had a size 10. Finally,
weusedtheBMIandracedistributionsby
age decade from the National Health and
Nutrition Examination Survey III labora-
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numbers of both the men and women in
terms of BMI and race to be more repre-
sentative of the national population.
Logistic regression models were used
to assess the independent associations of
the three-level sleep difﬁculty complaints
and objective sleep duration with diabe-
tes. We adjusted for major confounding
factors expected to affect this relationship
(i.e., age, race, sex, BMI, smoking status,
alcohol consumption, depression, and
SDB). We further tested the interaction
between sleep difﬁculty complaints and
objective sleep duration using a 2 log-
likelihood ratio test in logistic regression
models. Because the interaction between
sleep difﬁculty complaints and objec-
tive sleep duration was not signiﬁcant,
we entered these two variables into the
model separately, except for the last
model (Model 3, Table 2), in which the
results were adjusted for each other.
Then we performed ﬁnal logistic regres-
sion models to include eight dummy
variables to represent all nine possible
combinations of sleep difﬁculty and
sleep duration and used persons with-
out insomnia/poor sleep and with 6h
ofsleepdurationasacommonreference
group (Table 3).
RESULTS— The demographic, clini-
cal, and sleep characteristics of the entire
sample and its subgroups, based on sleep
difﬁculty, and the three levels of objective
sleep duration and diabetes, are pre-
sented in Table 1. Insomnia was associ-
ated with a signiﬁcantly higher risk for
diabetes (odds ratio [OR] 1.84 [95% CI
1.05–3.20], P  0.05) in the ﬁrst basic
covariable adjusted model (Model 1, Ta-
ble 2). With the increases in the number
of potential confounding factors in the
model, the OR of insomnia and diabetes
remained very similar (changed 8%,
from 1.84 to 1.69), but the precision of
the estimation worsened, reﬂected by in-
creased width of 95% CI. Poor sleep was
associated with a slight, nonsigniﬁcant
increase of risk for diabetes. Finally, an
objective sleep duration of 5–6 h was
associated with a slight, nonsigniﬁcant
increase of risk for diabetes (1.35
[0.92–1.98]).
The risk of diabetes was synergisti-
cally and signiﬁcantly increased among
persons with both insomnia and short
sleep duration (Table 3). The presence of
both insomnia and an objective sleep du-
ration 5 h increased the odds for diabe-
tes by about 300% (OR 2.95 [95% CI
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who have no insomnia/poor sleep com-
plaint and slept for 6 h. In addition, the
joint effect of insomnia and a sleep dura-
tion of 5–6 h increased the odds for dia-
betesby200%(2.07[0.68–6.37]).The
association in subjects with poor sleep
and a short sleep duration was not
signiﬁcant.
Finally,objectiveshortsleepduration
in the absence of a sleep complaint was
associated with nonsigniﬁcant increased
oddsfordiabetes.TheORsremainedvery
similar to those reported in Table 3 after
we adjusted for number of wakes, num-
ber of sleep stage changes, percentage
of stage 1 sleep, and periodic limb
movements.
CONCLUSIONS— This is the ﬁrst
study to demonstrate that chronic insom-
nia associated with objectively measured
short sleep duration is a clinically signiﬁ-
cant risk factor for type 2 diabetes. This
increased risk is independent of comor-
bid conditions frequently associated with
insomnia or diabetes, such as age, race,
obesity, alcohol consumption, smoking,
SDB, periodic limb movements, or de-
pression. Furthermore, our ﬁndings sug-
gest that objective measures of sleep
duration in insomnia may be a useful
markerofthebiologicalseverityandmed-
ical impact of the disorder.
Several studies have examined the
association of “sleep disturbances” with
diabeteswithinconsistentﬁndings(13–
16,19). However, none of these studies
obtained objective sleep data or con-
trolled for sleep apnea, a major con-
founder, both for sleep disturbance and
increased incidence of type 2 diabetes.
In our study, the more severe insom-
nia(i.e.,complaintofinsomniaforatleast
1 year) was signiﬁcantly associated with
higher odds of diabetes in the basic ad-
justed model. Most important, severe in-
somnia in combination with an objective
sleep duration of 5 h was associated
with a 300% higher odds for diabetes
thanthesubjectswhodidnothaveasleep
complaintandsleptfor6h.Thesecond
highest odds ratio was found in the group
of insomniacs who slept 5–6 h, although
the association did not reach signiﬁcance.
These ﬁndings are consistent with the
data on insomnia and hypertension, for
which the strongest associations were
found in these two groups (5). Further,
thesedataareconsistentwithourhypoth-
esis and previous physiological studies,
whichshowedthattheHPAaxisandsym-
pathetic system activity is elevated in
insomniacs with objective short sleep du-
ration (6–11).
Insomnia based solely on clinical cri-
teria and after adjustment for multiple
variables was not associated with signiﬁ-
cant odds for diabetes. This ﬁnding is
consistent with the results of the Sleep
HeartHealthStudy(SHHS)(20).Further,
the milder form of insomnia, i.e., poor
sleepcombinedwithshortsleepduration,
was not associated with a signiﬁcant risk
for diabetes. This lack of signiﬁcance may
reﬂect, given the large conﬁdence inter-
vals, a relatively small number of patients
with diabetes in each subgroup and/or
lack of use of more sensitive measures of
glycemic status, i.e., a standard oral glu-
cose challenge, in our study. An alterna-
tive explanation is that a larger degree of
sleep disturbance is required to affect gly-
cemic status compared with blood pres-
sure, as is the case with sleep apnea for
which an association with diabetes has
been reported only in those with more
severe apnea (21).
Experimental studies have shown
thatacuteorshort-termmodestsleeploss
is associated with impaired glycemic con-
trol (22) and inﬂammation, a condition
that predisposes an individual to diabetes
(23). In this study in a general population
sample,wedidnotobserveanassociation
between objective sleep duration and di-
abetes. Several limitations may have re-
sulted in this lack of signiﬁcance, such as
a relatively small number of patients with
diabetes in each of the nine subgroups
(combination of insomnia complaints
and objective sleep measures), lack of
more sensitive measures of glycemic sta-
tus(i.e.,oralglucosetolerancetest),anda
single night sleep recording, which may
not be representative of the subjects’ typ-
ical sleep patterns. Notably, all previous
studies that have reported an association
betweensleepdurationanddiabeteswere
based on subject self-report (22). Addi-
tionalstudiesthatincludebothsubjective
and objective sleep measures and more
sensitive methods of glycemic status
should be conducted to address the issue
of long-term sleep restriction and
diabetes.
The data on the association of insom-
nia with hypertension and diabetes, as
well as previous reports on insomnia and
the stress system (6–8) and the auto-
nomic system (9–11), provide the basis
for a meaningful subtyping of chronic in-
somnia based on objective duration of
sleep. One subtype is associated with
Table 2—Multivariable adjusted ORs (95% CIs) of diabetes associated with insomnia or
objective sleep duration
Model 1 Model 2 Model 3
Sleep difﬁculty
Normal sleeping 1.00 1.00 1.00
Poor sleep 1.31 (0.91–1.90) 1.23 (0.84–1.80) 1.22 (0.83–1.78)
Insomnia 1.84 (1.05–3.20) 1.70 (0.95–3.02) 1.69 (0.95–3.02)
Sleep duration (h)
6 1.00 1.00 1.00
5–6 1.38 (0.94–2.02) 1.37 (0.93–2.00) 1.35 (0.92–1.98)
5 1.15 (0.77–1.71) 1.11 (0.74–1.65) 1.08 (0.72–1.61)
Model 1: adjusted for age, race, sex, BMI, and sampling weight. Model 2: adjusted for age, race, sex, BMI,
sampling weight, smoking, alcohol consumption, depression symptoms, and SDB. The interaction between
insomnia and sleep duration was not statistically signiﬁcant. Thus, these two variables were entered into the
model separately, except for model 3, in which the results were adjusted for each other.
Table 3—Multivariable adjusted ORs (95%
CIs)ofdiabetesassociatedwithinsomniaand
objective sleep duration
Sleep difﬁculty
and duration
Adjusted OR
(95% CI)*
Normal sleeping
6 h 1.00
5–6 h 1.45 (0.91–2.30)
5 h 1.10 (0.68–1.79)
Poor sleep
6 h 1.52 (0.87–2.65)
5–6 h 1.55 (0.80–3.01)
5 h 1.06 (0.53–2.15)
Insomnia
6 h 1.10 (0.40–3.03)
5–6 h 2.07 (0.68–6.37)
5 h 2.95 (1.24–7.03)
Interactionbetweeninsomniaandsleepdurationisnot
statistically signiﬁcant, P  0.75. *Adjusted for age,
race,sex,BMI,samplingweight,smoking,alcoholcon-
sumption, depression symptoms, and SDB.
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sleepduration,activationofthestresssys-
tem, and signiﬁcant medical sequelae,
such as hypertension and/or diabetes.
The other subtype is not associated with
physiological hyperarousal, i.e., normal
sleep duration, normal activity of the
stresssystem,andlackofsigniﬁcantmed-
ical sequelae. The diagnostic validity and
utility of this subtyping should be tested
in future studies.
The objective sleep duration in this
study was based on one night of poly-
somnography, which may not be repre-
sentative of the subjects’ habitual sleep
duration. However, in our previous stud-
ies, the association between objective
sleepdurationandhypercortisolemiawas
based on a four consecutive night sleep
laboratory protocol, which should better
represent the typical sleep proﬁle of the
subjects (6,7). It should be noted that, in
our study, we investigated the relative
sleep duration measured objectively (i.e.,
5 h of objective sleep is relatively
shorter than 6 h of sleep). Objective
sleep duration was used as an internally
valid marker of the severity of insomnia
and not as a recommended optimal sleep
duration for the general population,
which is beyond the scope of our study.
Finally, the proposed criterion of 7ha s
the cutoff point for “normal” sleep dura-
tion is based on self-reported duration,
whereas in large epidemiological studies,
i.e., the SHHS or Coronary Artery Risk
Development in Young Adults (CARDIA)
study, the average objective sleep dura-
tion is 6 h, which is very similar to that
of our sample (24,25). This duration is
independent of whether sleep was re-
cordedathome(SHHS)(24)orfor3con-
secutive nights with actigraphy (CARDIA
study) (25) or in the sleep laboratory
(Penn State Cohort) (17,18). The consis-
tency of the ﬁndings on the role of objec-
tivesleepdurationinpredictinginsomnia
severitybetweenthephysiologicalstudies
with multiple night recordings (6,7) and
the current epidemiological study based
on a single night recording increases our
conﬁdence about the replicability and
generalizability of the present ﬁndings.
Future researchers should explore the as-
sociation between insomnia, sleep dura-
tion, and diabetes using multiple night
recordings. Finally, our study is cross-
sectional and does not provide causality
in terms of the direction of the associa-
tion. However, based on large amounts of
clinical and research data, which have
documented that insomnia is associated
with physiological hyperarousal (2,6–
11), the most likely direction is that in-
somnia leads to diabetes.
In summary, insomnia with short
sleep duration is associated with a signif-
icant risk for diabetes to a degree compa-
rable to that for the other most common
sleep disorder, i.e., SDB (21). Given the
highprevalenceofthedisorderinthegen-
eral population and the widespread mis-
conception that this is a disorder of the
“worried well,” its diagnosis and appro-
priatetreatmentshouldbecomethetarget
of public health policy. Objective mea-
sures of sleep duration of insomnia may
serve as clinically useful predictors of the
medicalseverityofchronicinsomnia,and
there is a need for validation of practical,
easy-to-use, inexpensive methods, e.g.,
actigraphy, to measure sleep duration
outside of the sleep laboratory. Finally,
insomnia with objective short sleep dura-
tion may represent a phenotype within
chronic insomnia that may respond dif-
ferentially to treatment.
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